Paper Details

Paper Title

Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin.

Paper Journal Title

Mol Cancer Ther

Paper Citation Count

157

Paper Publication Year

2011

Bio Mention

Mesh Descriptor

Column Actions